Statistics
Publications
1
Citations
45
H-Index
1
Active since
2017
Affiliations
Regulus Therapeutics (United States)(Current)
Meital Gabay-Ryan is an author at Regulus Therapeutics (United States) specializing in rna interference, systemic drug delivery, and transgenic mouse models.
Publications per year
2017–2017
1
1
Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)
Renumathy Dhanasekaran, Meital Gabay-Ryan, Virginie Baylot et al. · Oncotarget · 2017 · 45 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–1 of 1